Keywords: Breast, Diffusion/other diffusion imaging techniques, treatment response prediction, biomarkers, neoadjuvant chemotherapy
In breast imaging, diffusion-based (DW) MRI delivers complementary quantitative value to conventional dynamic contrast enhanced MRI. ADC maps of tumor tissue calculated from DW-MRI, specifically mean ADC of the tumor region of interest, have shown promise for measuring early response to neoadjuvant chemotherapy (NAC). However, depending on intra-tumoral heterogeneity, other histogram-based ADC metrics may provide even better predictive performance than mean ADC, but are yet to be studied thoroughly. Here, we investigated nine ADC-based metrics regarding their predictive performance for NAC treatment response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords